ACO Name and Location

SolutionHealth ACO LLC
Previous Names: N/A
8 Prospect Street
Nashua, NH 03061

ACO Primary Contacts

Primary Contact Name Alisha Feightner
Primary Contact Phone Number 603-314-2831
Primary Contact Email Address Alisha.Feightner@SolutionHealth.org

Organizational Information

ACO Participants ACO Participant in Joint Venture
ELLIOT HOSPITAL OF THE CITY OF MANCHESTER Y
FOUNDATION MEDICAL PARTNERS INC. Y
SOUTHERN NEW HAMPSHIRE MEDICAL CENTER Y
ELLIOT PHYSICIANS NETWORK Y
ELLIOT PROFESSIONAL SERVICES Y

ACO Governing Body

Last Name

First Name

Title

Votes

Membership Type

ACO Participant Legal Business Name/DBA, if applicable

Baxter, MD

Greg

Elliot Health System President; SolutionHealth CCO

1

ACO Participant Representative

Elliot Hospital

Cooper-Piela

Rebecca

Quality Assurance and Quality Improvement Officer

1

ACO Participant Representative

Southern New Hampshire Medical Center
Feightner Alisha ACO Executive Director, Elliot VP Operational Excellence 0 Other SolutionHealth ACO LLC

Frechette

Brian

VP, Ambulatory Services

1

ACO Participant Representative

Elliot Physicians Network
Fryatt Valerie Compliance Officer 0 Other Southern New Hampshire Medical Center
Kreick Brad

SolutionHealth CEO

 1 ACO participant Representative SolutionHealth
Klunk, MD John L. Medical Director 1 ACO Participant Representative Elliot Physicians Network
MacKay Michael VP of Finance 1 ACO Participant Representative Southern New Hampshire Medical Center

McHugh

Colin

Southern New Hampshire Health System President

1

ACO Participant Representative

Southern New Hampshire Medical Center

Mintz, MD

Holly

Elliot Health System CMO

1

ACO Participant Representative

Elliot Physicians Network

Ryan

Michael (Jerry)

Medicare Beneficiary Representative

1

Medicare Beneficiary Representative

Medicare Beneficiary Representative

Handa, MD

Ashima

Primary Care Provider

1

ACO Participant Representative

Foundation Medical Partners, Inc.

Tedesco, MD

Richard

Primary Care Provider

1

ACO Participant Representative

Elliot Physicians Network, LLC
Turilli Mike Elliot Health System CFO 1 ACO Participant Representative Elliot Hospital
Vella, MD Salvatore Chief Medical Officer 1 ACO Participant Representative Foundation Medical Partners, Inc.

Key ACO Clinical and Administrative Leadership:

Alisha Feightner, MPH ACO Executive 
John Klunk, MD Medical Director
Val Fryatt, MBA, CHC, COC, CPC, CRC Compliance Officer
Rebecca Cooper-Piela, MS, APRN-BC, CHCQM Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership

Committee Name

Committee Leader Name and Position

Quality and Delivery of Care Committee

L. John Klunk, MD, Chief Quality Officer,
Medical Director, Co-chair

Rebecca Cooper-Piela, MS, APRN-BC, CHCQM,
AVP Chief Quality Officer, Co-chair

Compliance Committee

Valerie Fryatt, MBA, CHC, COC, CPC, CRC,
Chief Compliance Officer, Chair

Data & Analytics Committee

Jon Michael Vore, DO, Co-Chair, Chief Medical Informatics Officer

Peter Demary, MPH, Co-Chair, Director of Value-Based Care and ACO Operations

Finance & Contracting Committee

Sheryl Paquin, Manager of Managed Care Reimbursement, Interim Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
  • Performance Year 2021, $0
  • Second Agreement Period
  • Performance Year 2020, $0
  • First Agreement Period
  • Performance Year 2019, $0

Shared Savings Distribution

  • Third Agreement Period
      • Performance Year 2021
          • Proportion invested in infrastructure: n/a%
          • Proportion invested in redesigned care processes/resources: n/a%
          • Proportion of distribution to ACO participants: n/a%
  • Second Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: n/a%
      • Proportion invested in redesigned care processes/resources: n/a%
      • Proportion of distribution to ACO participants: n/a%
  • First Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: n/a%
      • Proportion invested in redesigned care processes/resources: n/a %
      • Proportion of distribution to ACO participants: n/a %

Quality Performance Results

2021 Quality Performance Results

Quality performance results are based on CMS Web Interface

Measure # Measure Name Rate ACO Mean
1 Diabetes: Hemoglobin A1c (HbA1c) Poor Control 11.13 12.46
134 Preventative Care and Screening: Screening for Depression and Follow-up Plan *n/a *n/a
236 Controlling High Blood Pressure 73.3 74.87
318 Falls: Screening for Future Fall Risk 81.31 87.03
110 Preventive Care and Screening: Influenza Immunization 78.93 80.52
226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 85.29 80.97
370 Depression Remission at Twelve Months n/a* n/a*
113 Colorectal Cancer Screening 81.57 73.63
112 Breast Cancer Screening 73.87 75.11
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease *n/a *n/a
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 0.1625 0.154
MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC 40.02 33.99
CAHPS-1 Getting Timely Care, Appointments, and Information 82.5 84.67
CAHPS-2 How Well Providers Communicate 91.6 93.56
CAHPS-3 Patient’s Rating of Provider 90.4 92.19
CAHPS-4 Access to Specialists 75.72 78.8
CAHPS-5 Health Promotion and Education 62.98 61.61
CAHPS-6 Shared Decision Making 54.83 60.89
CAHPS-7 Health Status and Functional Status 72.72 71.78
CAHPS-8 Care Coordination 82.62 85.66
CAHPS-9 Courteous and Helpful Office Staff 91.91 91.88
CAHPS-11 Stewardship of Patient Resources 20.02 24.71

 

*Please note, the following quality measures are not included for public reporting due to low sample size:

  • Quality ID #:134: Preventative Care and Screening: Screening for Depression and Follow-up Plan
  • Quality ID # 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
  • Quality ID #:370 Depression Remission at 12 months

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov